Breaking News Instant updates and real-time market news.

HALO

Halozyme

$17.16

0.33 (1.96%)

04:55
04/11/19
04/11
04:55
04/11/19
04:55

Halozyme management to meet with JPMorgan

Meetings to be held in Europe on April 9-11 hosted by JPMorgan.

  • 11

    Apr

  • 02

    May

  • 22

    May

  • 23

    May

HALO Halozyme
$17.16

0.33 (1.96%)

11/27/18
JEFF
11/27/18
NO CHANGE
Target $9
JEFF
Underperform
Jefferies still sees low likelihood of success for Halozyme's PEGPH20
Following the announced change in the Phase 3 endpoint, Jefferies analyst Eun Yang continues to view probability for success of Halozyme Therapeutics's PEGPH20 in pancreatic cancer as low. The change in the HALO-301 endpoint/data analysis "dampens our confidence further," Yang tells investors in a research note. HALO-301 is a phase 3 global, randomized, double-blind placebo controlled clinical trial evaluating investigational new drug PEGPH20 as a first-line therapy for potential treatment of patients with metastatic pancreas cancer. The analyst remains cautious on Halozyme shares with an Underpeform rating and $9 price target.
11/27/18
JMPS
11/27/18
NO CHANGE
Target $21
JMPS
Outperform
Halozyme Phase 3 trial amendment makes sense, says JMP Securities
After Halozyme announced that it is amending the design of the Phase 3 trial evaluating PEGPH20 in front-line pancreatic cancer to make overall survival the sole primary endpoint, JMP Securities analyst Jason Butler said he thinks the change makes sense and is neutral to his thesis. While the change pushes out first results by about 6-9 months, the "outcome will be definitive," said Butler, who reiterates an Outperform rating and $21 price target on Halozyme shares.
01/11/19
WELS
01/11/19
NO CHANGE
WELS
Outperform
Halozyme undervalued relative to 'de -risked' assets, says Wells Fargo
Wells Fargo analyst Jim Birchenough reiterates an Overweight rating on Halozyme Therapeutics following this week's update and 2019 outlook. The analyst continues to view the company as undervalued relative to its "highly de -risked" lead Enhanze assets. He sees "significant option value" to the broader Enhanze opportunity and PEGPH20 data.
02/05/19
PIPR
02/05/19
NO CHANGE
Target $161
PIPR
Overweight
Piper says argenx cusatuzumab study could enable registration if responses hold
Piper Jaffray analyst Edward Tenthoff reiterated an Overweight rating and $161 price target on argenx (ARGX) after the company announced a collaboration agreement with Halozyme (HALO). In a research note to investors, Tenthoff says that an ongoing Phase II study of cusatuzumab, which was licensed to Janssen (JNJ) after demonstrating a 92% response rate in AML at ASH, could enable registration if responses hold. The company will host an R&D Day in NYC on May 16 to introduce ARGX-117 and also expects the company will introduce ARGX-118.

TODAY'S FREE FLY STORIES

ADSK

Autodesk

$168.15

-5.96 (-3.42%)

14:49
05/23/19
05/23
14:49
05/23/19
14:49
Options
Autodesk options imply 8.6% move in share price post-earnings, below median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 12

    Jun

GWR

Genesee & Wyoming

$85.51

-0.55 (-0.64%)

, BX

Blackstone

$40.81

-0.89 (-2.13%)

14:48
05/23/19
05/23
14:48
05/23/19
14:48
Periodicals
Genesee & Wyoming pursued by Blackstone, Brookfield, others, Bloomberg says »

Blackstone (BX),…

GWR

Genesee & Wyoming

$85.51

-0.55 (-0.64%)

BX

Blackstone

$40.81

-0.89 (-2.13%)

BAM

Brookfield

$46.47

-0.33 (-0.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Jun

  • 19

    Jun

  • 08

    Aug

  • 13

    Nov

NXPI

NXP Semiconductors

$90.85

-2.79 (-2.98%)

14:45
05/23/19
05/23
14:45
05/23/19
14:45
Options
NXP Semiconductors call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 29

    May

  • 13

    Jun

FE

FirstEnergy

$42.94

0.31 (0.73%)

14:36
05/23/19
05/23
14:36
05/23/19
14:36
Periodicals
Breaking Periodicals news story on FirstEnergy »

Ohio advances bill that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HII

Huntington Ingalls

$202.83

-6.34 (-3.03%)

14:35
05/23/19
05/23
14:35
05/23/19
14:35
Hot Stocks
Huntington Ingalls VP William Ermatinger sells almost $400K in company shares »

Huntington Ingalls VP…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

QRVO

Qorvo

$59.38

-0.83 (-1.38%)

14:35
05/23/19
05/23
14:35
05/23/19
14:35
Options
Qorvo put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UIS

Unisys

$9.44

-0.3 (-3.08%)

14:31
05/23/19
05/23
14:31
05/23/19
14:31
Initiation
Unisys initiated  »

Unisys initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

MAXR

Maxar Technologies

$8.20

1.05 (14.69%)

14:28
05/23/19
05/23
14:28
05/23/19
14:28
Hot Stocks
NASA confirms contract with maximum $375M value awarded to Maxar Technologies »

NASA announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BX

Blackstone

$40.84

-0.86 (-2.06%)

, PLD

Prologis

$76.02

-0.55 (-0.72%)

14:27
05/23/19
05/23
14:27
05/23/19
14:27
Periodicals
Blackstone, Prologis separately bidding for U.S. unit of GLP, WSJ says »

Blackstone (BX) and…

BX

Blackstone

$40.84

-0.86 (-2.06%)

PLD

Prologis

$76.02

-0.55 (-0.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jun

  • 04

    Jun

  • 11

    Jun

GLNG

Golar LNG

$19.17

-0.82 (-4.10%)

14:25
05/23/19
05/23
14:25
05/23/19
14:25
Options
Golar LNG call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JPM

JPMorgan

$107.68

-3.11 (-2.81%)

14:24
05/23/19
05/23
14:24
05/23/19
14:24
Periodicals
JPMorgan severs ties with OxyContin maker Purdue Pharma, Reuters says »

JPMorgan has severed ties…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 03

    Jun

  • 11

    Jun

  • 16

    Jul

MAXR

Maxar Technologies

$8.04

0.89 (12.45%)

14:18
05/23/19
05/23
14:18
05/23/19
14:18
Hot Stocks
Breaking Hot Stocks news story on Maxar Technologies »

Maxar Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
05/23/19
05/23
14:17
05/23/19
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FL

Foot Locker

$53.15

-1.05 (-1.94%)

14:16
05/23/19
05/23
14:16
05/23/19
14:16
Recommendations
Foot Locker analyst commentary at Canaccord »

Canaccord says buyers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 09

    Jul

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
05/23/19
05/23
14:16
05/23/19
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:15
05/23/19
05/23
14:15
05/23/19
14:15
Conference/Events
Wolfe Research pharmaceuticals analyst to hold analyst/industry conference call »

Pharmaceuticals Analyst…

VXX

iPath S&P 500 VIX Short-Term Futures

$29.12

1.91 (7.02%)

14:10
05/23/19
05/23
14:10
05/23/19
14:10
Options
Bullish spread opened in VIX Short-term Futures Fund »

Bullish spread opened in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:06
05/23/19
05/23
14:06
05/23/19
14:06
Conference/Events
Wolfe Research managing director to hold an analyst/industry webinar »

Quantitative Analysis,…

MAXR

Maxar Technologies

$7.59

0.44 (6.15%)

14:06
05/23/19
05/23
14:06
05/23/19
14:06
Hot Stocks
Maxar Technologies up 17% after selection for NASA project »

Maxar Technologies shares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLUU

Glu Mobile

$8.32

-0.185 (-2.18%)

14:05
05/23/19
05/23
14:05
05/23/19
14:05
Options
Glu Mobile call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

  • 08

    Jun

  • 10

    Jun

  • 10

    Jun

  • 13

    Nov

MAXR

Maxar Technologies

$7.32

0.17 (2.38%)

14:03
05/23/19
05/23
14:03
05/23/19
14:03
Periodicals
NASA selects Maxar for first part of lunar gateway, WFTV reports »

Maxar Technologies was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BX

Blackstone

$40.90

-0.8 (-1.92%)

, PLD

Prologis

$76.22

-0.35 (-0.46%)

14:00
05/23/19
05/23
14:00
05/23/19
14:00
Periodicals
Breaking Periodicals news story on Blackstone, Prologis »

Blackstone, Prologis bid…

BX

Blackstone

$40.90

-0.8 (-1.92%)

PLD

Prologis

$76.22

-0.35 (-0.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jun

  • 04

    Jun

  • 11

    Jun

BX

Blackstone

$40.90

-0.8 (-1.92%)

, PLD

Prologis

$76.22

-0.35 (-0.46%)

13:59
05/23/19
05/23
13:59
05/23/19
13:59
Periodicals
Breaking Periodicals news story on Blackstone, Prologis »

Blackstone, Prologis…

BX

Blackstone

$40.90

-0.8 (-1.92%)

PLD

Prologis

$76.22

-0.35 (-0.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jun

  • 04

    Jun

  • 11

    Jun

MAXR

Maxar Technologies

$7.00

-0.15 (-2.10%)

13:56
05/23/19
05/23
13:56
05/23/19
13:56
Periodicals
Breaking Periodicals news story on Maxar Technologies »

Maxar selected by NASA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSM

TSMC

$37.86

-0.96 (-2.47%)

13:55
05/23/19
05/23
13:55
05/23/19
13:55
Options
Taiwan Semi put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.